Zacks: Brokerages Expect Encompass Health Corp (NYSE:EHC) to Announce $0.82 Earnings Per Share

Equities analysts forecast that Encompass Health Corp (NYSE:EHC) will announce $0.82 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for Encompass Health’s earnings. The lowest EPS estimate is $0.78 and the highest is $0.96. Encompass Health posted earnings per share of $0.80 in the same quarter last year, which indicates a positive year-over-year growth rate of 2.5%. The company is expected to announce its next earnings report on Thursday, February 6th.

On average, analysts expect that Encompass Health will report full year earnings of $3.87 per share for the current year, with EPS estimates ranging from $3.83 to $4.00. For the next fiscal year, analysts expect that the firm will report earnings of $3.72 per share, with EPS estimates ranging from $3.60 to $3.93. Zacks’ EPS calculations are a mean average based on a survey of research firms that that provide coverage for Encompass Health.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, October 28th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.89 by $0.04. Encompass Health had a return on equity of 23.89% and a net margin of 7.07%. The firm had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.16 billion.

EHC has been the subject of several research analyst reports. Deutsche Bank initiated coverage on Encompass Health in a research report on Tuesday, September 17th. They issued a “hold” rating and a $70.00 price objective for the company. Bank of America upgraded Encompass Health to a “buy” rating in a research report on Friday, September 6th. Finally, ValuEngine downgraded Encompass Health from a “buy” rating to a “hold” rating in a research report on Wednesday, October 30th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Encompass Health has an average rating of “Buy” and an average target price of $71.75.

EHC traded up $0.63 during trading on Wednesday, hitting $71.18. The company’s stock had a trading volume of 489,131 shares, compared to its average volume of 740,451. The firm’s 50 day moving average price is $68.71 and its two-hundred day moving average price is $63.90. The company has a quick ratio of 0.97, a current ratio of 0.97 and a debt-to-equity ratio of 1.94. Encompass Health has a 12 month low of $56.74 and a 12 month high of $74.52. The stock has a market capitalization of $6.97 billion, a price-to-earnings ratio of 19.61, a price-to-earnings-growth ratio of 2.07 and a beta of 0.85.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.28 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.57%. Encompass Health’s payout ratio is currently 30.85%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Story: Analyzing a company’s cash flow statement

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.